ACUTA CAPITAL PARTNERS, LLC
CIK
1582844
Location
REDWOOD CITY, CA
Portfolio Value
Small
$143,494,663
Diversification
Diversified
Filing Date
Global Rank
#5,329
/ 8,700
▲ 2411
Top Industry
Biotechnology
97.1%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
26 quarters · since Mar 2020
Portfolio Concentration
23 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
19.3%
−5.1 pts
Top 5
54.3%
−2.0 pts
Top 10
73.7%
−4.5 pts
HHI
877
Diversified−125
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $143,494,663 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WHWK | Whitehawk Therapeutics, Inc. | +1,275,510 | 4,685,912 | $21,461,476 | |
| DSGN | Design Therapeutics, Inc. | +136,664 | 282,564 | $4,088,701 | |
| AVTX | Avalo Therapeutics, Inc. | +125,500 | 186,308 | $3,442,971 | |
| TSHA | Taysha Gene Therapies, Inc. | +122,344 | 561,808 | $3,825,912 | |
| MLTX | MoonLake Immunotherapeutics | +23,892 | 215,652 | $4,198,744 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | +17,048 | 168,115 | $3,019,345 | |
| STRO | Sutro Biopharma, Inc. | +826 | 270,251 | $8,972,333 | |
| SRZN | Surrozen, Inc./DE | +548 | 173,395 | $4,499,600 | |
| ARGX | Argenx SE | +15 | 4,705 | $4,365,157 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −253,863 | 595,213 | $1,303,516 | |
| ERAS | Erasca, Inc. | −89,376 | 265,199 | $4,858,445 | |
| OCUL | Ocular Therapeutix, Inc | −59,627 | 532,481 | $5,228,963 | |
| TNGX | Tango Therapeutics, Inc. | −50,882 | 390,949 | $12,221,065 | |
| DRUG | Bright Minds Biosciences Inc. | −19,251 | 92,745 | $6,510,699 | |
| PRAX | Praxis Precision Medicines, Inc. | −2,105 | 82,796 | $27,719,272 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AVBP | ArriVent BioPharma, Inc. | 218,694 | $7,597,429 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 507,801 | $6,753,753 | |
| AVLN | Avalyn Pharma Inc. | 115,000 | $3,785,800 | |
| ARTV | Artiva Biotherapeutics, Inc. | 260,416 | $2,526,035 | |
| CTNM | Contineum Therapeutics, Inc. | 63,095 | $1,034,127 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| OCS | Oculis Holding AG | 98,339 | $2,614,834 | |
| RVMD | Revolution Medicines, Inc. | 26,069 | $2,535,210 | |
| IDYA | IDEAYA Biosciences, Inc. | 48,584 | $1,618,818 | |
| TRDA | Entrada Therapeutics, Inc. | 89,358 | $1,127,697 | |
| MAZE | Maze Therapeutics, Inc. | 19,335 | $577,149 | |
| UNCY | Unicycive Therapeutics, Inc. | 57,959 | $381,370 | |
| — | 495,772 | $0 | ||
| No positions match the current search. | ||||
23 tracked positions ·
$143,494,663 total
· filing declares
23 positions · $143,494,671
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 82,796 | $27,719,272 | 19.32% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Added | 4,685,912 | $21,461,476 | 14.96% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 390,949 | $12,221,065 | 8.52% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 270,251 | $8,972,333 | 6.25% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 218,694 | $7,597,429 | 5.29% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
NEW | 507,801 | $6,753,753 | 4.71% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 92,745 | $6,510,699 | 4.54% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 532,481 | $5,228,963 | 3.64% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Reduced | 265,199 | $4,858,445 | 3.39% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Added | 173,395 | $4,499,600 | 3.14% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 4,705 | $4,365,157 | 3.04% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Added | 215,652 | $4,198,744 | 2.93% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Added | 282,564 | $4,088,701 | 2.85% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Held | 709,500 | $3,937,725 | 2.74% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 561,808 | $3,825,912 | 2.67% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 115,000 | $3,785,800 | 2.64% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 186,308 | $3,442,971 | 2.40% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Added | 168,115 | $3,019,345 | 2.10% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
NEW | 260,416 | $2,526,035 | 1.76% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 595,213 | $1,303,516 | 0.91% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 2,224 | $1,205,029 | 0.84% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
NEW | 63,095 | $1,034,127 | 0.72% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 28,919 | $938,566 | 0.65% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.